Sugimoto, T <br/><br/>
Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR.  [electronic resource] 

 -  American journal of hematology  Jun 2000 
 - 101-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1096-8652(200006)64:2<101::aid-ajh5>3.0.co;2-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Transplantation<br/>Chromosomes, Human, Pair 21<br/>Chromosomes, Human, Pair 8<br/>Combined Modality Therapy<br/>Computer Systems<br/>Core Binding Factor Alpha 2 Subunit<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Oncogene Proteins, Fusion--genetics<br/>RNA, Messenger--analysis<br/>RUNX1 Translocation Partner 1 Protein<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sensitivity and Specificity<br/>Transcription Factors--genetics<br/>Translocation, Genetic<br/>Transplantation, Homologous